Qinqin Cheng
About Qinqin Cheng
Qinqin Cheng is a Senior Scientist at Bristol Myers Squibb with over 10 years of research experience in developing therapeutics and a strong background in chemical biology and biotechnology.
Company
Qinqin Cheng is currently working as a Senior Scientist at Bristol Myers Squibb. She is based in Redwood City, California, United States. Bristol Myers Squibb is well-known for its work in biopharmaceuticals, focusing on discovering, developing, and delivering innovative medicines for patients with serious diseases.
Title
Qinqin Cheng holds the position of Senior Scientist. She has over a decade of experience in the field, particularly in developing therapeutics based on engineered exosomes, proteins, and antibodies.
Education and Expertise
Qinqin Cheng earned her Bachelor’s degree in Biotechnology from Hainan University, where she studied from 2006 to 2010. She went on to complete a Ph.D. in Chemical Biology at the University of Science and Technology of China, a journey that spanned from 2010 to 2015. Her expertise lies in protein engineering for immune-oncology, NAD analogues, platinum-based anti-tumor drugs, and drug delivery systems.
Professional Background
Before joining Bristol Myers Squibb, Qinqin Cheng held the position of Research Associate at the University of Southern California for six months in 2021. Prior to that, she was a Postdoctoral Researcher at the same institution from 2016 to 2021. Her work has always centered around research and innovation in various facets of biotechnology.
Achievements
Qinqin Cheng has a substantial portfolio of achievements, including 22 publications and 3 patents, which have collectively garnered over 500 citations. She has demonstrated excellence and productivity in independent research and possesses strong organizational skills, enabling her to collaborate effectively with multiple research groups. Additionally, she has excellent communication, writing, and public presentation skills.